Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
Merck(MRK) stock is priced at $153.16, giving the company a market capitalization of 376.29B. It carries a P/E multiple of 121.93 and pays a dividend yield of 2.20%.
During the trading session on 2026-08-23, Merck(MRK) shares reached a daily high of $154.49 and a low of $148.59. At a current price of $153.16, the stock is +3.1% higher than the low and still -0.9% under the high.
Trading activity shows a volume of 15.98M, compared to an average daily volume of 12.23M.
The stock's 52-week range extends from a low of $77.58 to a high of $154.49.
The stock's 52-week range extends from a low of $77.58 to a high of $154.49.
MRK News
Tempus AI (TEM +9.06%) stock posted massive gains this week despite valuation pressures across the broader market. The healthcare artificial intelligence (AI) s...
Merck & Company ( (MRK) ) has risen by 12.19%. Read on to learn why. Summer Sale - Claim 70% Off TipRanks Unlock powerful investing tools with TipRanks Premium...
Biotech and Pharma Can mRNA Cure Cancer? Inside the Pipeline Risks for Biotech’s Biggest Players In this article MRNA MRK BNTX PFE ARCT Moderna and Merck said a...
Analyst ratings
68%
of 31 ratingsMore MRK News
Eurozone manufacturing is now at its strongest point in four years, even as many investors still watch headlines about growth with caution. That gap between imp...
Johnson & Johnson JNJ and Merck MRK are two of the largest U.S. healthcare companies, making them compelling stocks to compare. Both companies have strong posi...
Goldman Sachs raised the firm’s price target on Merck (MRK) to $160 from $140 and keeps a Buy rating on the shares. Merck’s shares surged after positive Phase 3...
Central banks are still warning about sticky inflation, and that keeps a tight focus on interest rates and cash. In this setting, companies that already generat...
Technology Moderna's Cancer Vaccine: Are Investors Putting The Cart Before The Horse? Licensing Messenger RNA companies collectively added $92 billion to their...
Merck & Co. (MRK), a U.S. pharmaceutical firm, got a major boost on Thursday, August 20, after investment banks Morgan Stanley (MS), UBS (UBS) and Goldman Sachs...
Moderna Plunges 20% One Day After Cancer Vaccine Breakthrough Sent Shares Up 177% By Thomas Richmond Published Aug 20, 12:22PM EDT Quick Read Moderna (MRNA) s...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.